Healthy Skepticism Library item: 6887

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Lexchin J.
Re: the promotion of Zaditen (ketotifen)
1999 Jan;

Abstract:

In Mexico Novartis is marketing Zaditen (ketotifen) for the treatment of asthma and the promotional literature makes a number of claims. MaLAM has examined the scientific literature and finds that these claims cannot be supported.

Keywords:
*analysis/Mexico/developing countries/Zaditen/ketotifen/asthma/Novartis/quality of information/Medical Lobby for Appropriate Marketing/MaLAM/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES